Search Results 201-210 of 15259 for Polycystic kidney disease
Caroline (Carli) R. Sussman, Ph.D., is a nephrology researcher at Mayo Clinic who studies kidney development and polycystic kidney disease (PKD).
A Study To Evaluate RGLS4326 To Treat Autosomal Dominant Polycystic Kidney Disease ... Must have estimated GFR at Screening between 30 to 90 mL/min/1.73 m^2 ...
Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40. Pediatr Nephrol. 2025 Jun; 40 (6):1997-2007 Epub ...
The purpose of this study is to expand the currently limited knowledge about Autosomal Dominant Polycystic Kidney Diseases (ADPKD) by creating a registry of ...
Chronic kidney disease happens when the kidneys are damaged for more than a few months. The kidneys clean the blood by removing waste and extra fluid, which ...
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease ... Polycystic Kidney Disease: A Biomarker of Disease Progression and ...
Some people, including African Americans, Native Americans and Asian Americans, are at higher risk of developing chronic kidney disease. March is National ...
The Chebib lab has numerous research focus areas related to autosomal dominant polycystic kidney disease (ADPKD). Mechanisms of cystogenesis and disease ...
Xiaogang Li, Ph.D., conducts research at Mayo Clinic on polycystic kidney disease (PKD), cyst formation, epigenetics and inflammation.
... patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD). Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.